Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma

Phase III randomised-controlled trial for patients with unilateral malignant pleural mesothelioma (MPM).

Trial Details

NCT ID
NCT05655078
Phase
NA
Sponsor
University College, London
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Proton beam therapy
Locations (sample)
  • Eastbourne, East Sussex, United Kingdom|50.76871,0.28453
  • Saint Leonards-on-Sea, East Sussex, United Kingdom|50.85565,0.5452
  • Reading, England, United Kingdom|51.45625,-0.97113
  • Southend, Essex, United Kingdom|55.31667,-5.63333
  • Portsmouth, Hampshire, United Kingdom|50.79899,-1.09125

Key Eligibility Criteria

  • Patients ≥18 years of age, with biopsy confirmed MPM and histological subtyping (epithelioid or non-epithelioid)
  • N0 or N1 and M0 disease
  • Written informed consent
  • Patient and local/regional MDT opt for active surveillance and deferral of SACT until clinical or radiological progression

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →